Why Peptides Cost So Much (The Real Supply Chain Markup)

Watch the full video on Rumble: https://rumble.com/v7ht21u-why-peptides-cost-so-much-the-real-supply-chain-markup.html

Why Peptides Cost So Much (The Real Supply Chain Markup)

The price you pay for a peptide has almost nothing to do with what it costs to make. Most of my peptides, if you've seen, are more competitively priced than anybody in the market, but we're still making a 10x return on what we sell. That should tell you everything about what the rest of the market is doing.

Follow a vial backwards and the whole thing makes sense.

The chain starts with the API, the active pharmaceutical ingredient, which is the raw powder itself before anyone puts it in a vial or puts a label on it. Those raw materials are produced at scale by pharmaceutical manufacturers, mostly in China, in volumes measured in kilograms.

From there the powder has to get into the United States legally, and that requires a pharmaceutical broker's license, which is the permission to import raw drug material rather than a finished drug. Then it gets synthesized, filled, capped, and tested, and only after all of that does it reach you as a finished product.

Every one of those steps costs real money. Added together, they still do not come close to what the market charges.

The early players figured this out before anyone else did, and what they were charging was, in some cases, 100 times more than the actual cost of it, and buyers kept paying it anyway. And that's how they got big.

The whole category was built on nobody outside the supply chain knowing what a gram of raw material actually costs.

So when I started to do my own research and found out about the process and the regulatory things around peptides and how it works, what we started doing was we started importing and testing our own Chinese peptides. And that's worked very well.

I have since moved further up the chain. We now source from a US-based synthesizer out of Miami, and everything arrives pre-tested. 100% of everything that we sell is produced here in the United States.

That phrase gets abused in this industry, so it is worth being precise about it.

What they do is they import the APIs, which is the raw materials from pharmaceutical manufacturers in China, through a legal pharmaceutical broker's license. The raw material still originates overseas, because that is where the capacity is, and the same suppliers sell to Eli Lilly and Novo Nordisk. The synthesis, the filling, and the testing happen in Miami.

So "made in the USA" describes where the compounding and quality control happen, not where the atoms came from. Anyone claiming an entirely domestic chain from raw material onward is describing a facility that mostly does not exist at this scale.

The economics get strange fast. If I come in with all my peptides at 30% or 40% less of what everyone else is selling them for, it'll actually affect my trust level because people won't believe that what I'm selling is real because it's so cheap.

Price became a proxy for legitimacy, because buyers had no other signal to go on. No pharmacy label, no insurance code, no prescribing doctor, nothing but a figure printed on a webpage. So the number started doing the work that documentation should have been doing, and the expensive vendor read as the safe one.

Which means the useful thing you can do is stop reading price as evidence and start asking for the things that are. Find out where the synthesis actually takes place. Ask whether the vials come pre-tested or whether testing was done on a different batch than the one you received. Ask for a certificate of analysis tied to your lot number, not a generic one posted once and reused.

A vendor who can answer those three questions at a low price is selling you the same molecule as the vendor who cannot answer them at four times the cost.

The markup was never paying for better peptides. It was paying for the feeling that you were not being scammed, which is the one thing a high price can never actually prove.